Navigation Links
Neptune Krill Oil, NKO(R), enters WALGREENS, the largest U.S. retail pharmacy chain, under the brand name Schiff(R) MegaRed(TM)
Date:9/15/2008

LAVAL, QC, Sept. 15 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) reported today that its distributor Schiff Nutrition International Inc. has launched Schiff(R) MegaRed(TM) containing Neptune Krill Oil (NKO(R)) in Walgreens, which represents the largest retail pharmacy chain in the United States with over 6,400 drug stores nationwide. Schiff(R) MegaRed(TM) has been made available at all locations.

Walgreens, founded in 1901, is considered the leader in innovative drugstore retailing setting new standards in the industry with its modern store and pharmacy features. Walgreens reported fiscal year 2007 revenues of over $53 billion and is serving 5 million customers daily chainwide. Walgreens reports that it expects to operate more than 7,000 stores in 2010(1).

"We continue to execute on our expansion strategy to seek strong penetration in mass retail channels, and now with distribution in Costco and Walgreens, the consumer mass market represents a fast growing sales segment for Neptune driven by brand recognition and consumer acceptance. Neptune Krill Oil's unique composition of proprietary bioactive ingredients of functionalized phospholipid omega-3 fatty acids and powerful anti-oxidants enables the positioning of NKO(R) as a premium product in the marketplace," stated Thierry Houillon, Vice-President, Nutraceutical of Neptune.

"Premium products within the worldwide marine omega-3 market such as Neptune Krill Oil are gaining major market share driven by consumer demand for natural health and wellness products with proven therapeutic benefits. The high-end omega-3 market is growing at an annual rate of between 20 and 30 percent. This trend will provide the Company, as a recognized innovator and market leader, with an opportunity to generate high sales growth of its products which enforces the Company's strategic plan to expand productivity and capacity by rapidly completing the in-ho
'/>"/>

SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neptune Reports Year End Financial Results - Neptune Records 18% Sales Increase and 43% EBITDA Increase in Year End Results
2. Neptune Technologies & Bioressources Inc. Reports First Quarter Results and Business Update
3. Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board
4. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
5. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
6. Neptune Technologies receives GRAS notification in the United States
7. Neptune Technologies expands into medicinal markets in Asia Pacific
8. Neptune Technologies patent granted for novel phospholipids in multiple diseases and pharmaceutical applications
9. The Omega-3 Industry Leader, Croda Health Care, selects Neptune Technologies Ingredients for New Essentially Brand
10. Neptune Technologies & Bioressources Inc. reports third quarter results and update on strategic milestones
11. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Superior offspring without genetic modification 2Study finds new relationship between gene duplication and alternative splicing in plants 2Study finds new relationship between gene duplication and alternative splicing in plants 3Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 1Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 2Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 3Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 4Palomar to Commercialize FDA Cleared Over The Counter Home Use Wrinkle Treatment Laser Device Without Johnson 26amp 3B Johnson 5536 5Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 1Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 2Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 3Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 4Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 5Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 6Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 7Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 8Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 9Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 10Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 11Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 12Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 13Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 14Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 15Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 16Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 17Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 18Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 19Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 20Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 21Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 22Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 23Reportlinker Adds Global Top 10 Chemical Companies Industry Financial and SWOT Analysis 5530 24Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 1Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 2Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 3Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 4Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 5Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 6Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 7Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 8Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 9Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 10Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014 3A Policy environment market structure competitive landscape growth oppo 5528 11